StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna Deferred revenue by Quarter

Deferred revenue — Total customer deposits & Advance Purchase Agreements (APAs) ($M) ($M)

QuarterlyAnnual

Moderna Deferred revenue: $442M in Q2 2026, up 56.2% from a year earlier.

Latest, Q2 2026
442
Period ended Jun 30, 2026
Change on a year earlier
+56.2%
283 in Q2 2025
History
31 quarters
Since Q4 2018
Sources
30
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-07-31) ↗

Reported in Form 10-Q / 10-K Note 2 (Contract Liabilities & Deferred Revenue).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDeferred revenue — Total customer deposits & Advance Purchase Agreements (APAs) ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026442+56.2%Form 10-Q (filed 2026-07-31) ↗
Q1 2026Mar 31, 2026256+39.9%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 2025252+19.4%Form 10-Q (filed 2026-07-31) ↗
Q3 2025Sep 30, 2025320-32.5%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 2025283-64.5%Form 10-Q (filed 2025-08-01) ↗
Q1 2025Mar 31, 2025183-70.3%Form 10-Q (filed 2025-05-01) ↗
Q4 2024Dec 31, 2024211-67.6%Form 10-K (filed 2026-02-20) ↗
Q3 2024Sep 30, 2024474-69.2%Form 10-Q (filed 2024-11-07) ↗
Q2 2024Jun 30, 2024797-54.0%Form 10-Q (filed 2024-08-01) ↗
Q1 2024Mar 31, 2024617-67.4%Form 10-Q (filed 2024-05-02) ↗
Q4 2023Dec 31, 2023651-76.0%Form 10-K (filed 2025-02-21) ↗
Q3 2023Sep 30, 20231,538-63.2%Form 10-Q (filed 2023-11-03) ↗
Q2 2023Jun 30, 20231,732-61.5%Form 10-Q (filed 2023-08-03) ↗
Q1 2023Mar 31, 20231,892-68.8%Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 20222,711-60.5%Form 10-K (filed 2024-02-23) ↗
Q3 2022Sep 30, 20224,177-50.7%Form 10-Q (filed 2022-11-03) ↗

Breakdown

What makes up deferred revenue

Cite this data

StockData. (2026). Moderna Deferred revenue ($M), quarterly Q4 2018–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/def-rev-total

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.